- Home
- AMRN vs VOR Comparison
AMRN vs VOR Comparison
Compare AMRN & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- VOR
- Stock Information
- Founded
- AMRN 1989
- VOR 2015
- Country
- AMRN Ireland
- VOR United States
- Employees
- AMRN N/A
- VOR N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- AMRN Health Care
- VOR Health Care
- Exchange
- AMRN Nasdaq
- VOR Nasdaq
- Market Cap
- AMRN 302.0M
- VOR 261.0M
- IPO Year
- AMRN 1993
- VOR 2021
- Fundamental
- Price
- AMRN $19.10
- VOR $31.69
- Analyst Decision
- AMRN Strong Sell
- VOR Buy
- Analyst Count
- AMRN 1
- VOR 6
- Target Price
- AMRN $12.00
- VOR $78.00
- AVG Volume (30 Days)
- AMRN 94.0K
- VOR 466.7K
- Earning Date
- AMRN 10-29-2025
- VOR 11-06-2025
- Dividend Yield
- AMRN N/A
- VOR N/A
- EPS Growth
- AMRN N/A
- VOR N/A
- EPS
- AMRN N/A
- VOR N/A
- Revenue
- AMRN $219,361,000.00
- VOR N/A
- Revenue This Year
- AMRN N/A
- VOR N/A
- Revenue Next Year
- AMRN N/A
- VOR N/A
- P/E Ratio
- AMRN N/A
- VOR N/A
- Revenue Growth
- AMRN N/A
- VOR N/A
- 52 Week Low
- AMRN $7.08
- VOR $2.62
- 52 Week High
- AMRN $20.43
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- AMRN 82.57
- VOR 57.25
- Support Level
- AMRN $15.24
- VOR $36.67
- Resistance Level
- AMRN $20.43
- VOR $49.95
- Average True Range (ATR)
- AMRN 0.80
- VOR 4.26
- MACD
- AMRN 0.39
- VOR -1.32
- Stochastic Oscillator
- AMRN 75.82
- VOR 21.45
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.